A mononuclear nonheme iron complex with higher affinity for O<sub>2</sub> than CO via hydrogen bonding.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42086585.
- Also identified by DOI 10.1038/s41467-026-72599-y.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dioxygen activation at iron centers is central to many biological and synthetic oxidation processes. In proteins, the reactivity and stability of iron-dioxygen intermediates are often controlled by secondary-sphere interactions such as hydrogen bonding. For example, hemoglobin stabilizes a Fe-O<sub>2</sub> adduct through distal hydrogen bonding, while hemerythrin employs hydrogen bonding to stabilize reduced oxygen species within a diiron active site, enabling reversible O<sub>2</sub> binding. Here we show that a mononuclear nonheme iron complex, [Fe<sup>II</sup>(DIG<sub>3</sub>tren)]<sup>2+</sup> (DIG<sub>3</sub>tren = tris(N',N"-diisopropylguanidinyl-2-ethyl)amine), reversibly reduces O<sub>2</sub> by two electrons to generate an iron(IV)-peroxido species. Strong hydrogen bonds from N - H groups of the ligand stabilize the O<sub>2</sub><sup>2-</sup> ligand, while the electron-rich guanidine donors promote the unusual Fe<sup>II</sup>-mediated two-electron reduction of O<sub>2</sub>. As a result, the complex exhibits higher affinity for O<sub>2</sub> than for CO due to preferential hydrogen-bond stabilization of the peroxido intermediate. These results demonstrate how secondary-sphere design can control both O<sub>2</sub> activation and ligand selectivity at iron centers.